CVE-2025-69009 identifies a missing authorization vulnerability in the kamleshyadav Medicalequipment product, affecting versions up to 1.0.9. This vulnerability arises from incorrectly configured access control mechanisms, allowing attackers to bypass authorization checks and perform unauthorized actions on the medical equipment. The vulnerability does not require any privileges or user interaction, and it is exploitable remotely over the network, as indicated by the CVSS vector (AV:N/AC:L/PR:N/UI:N). Although the confidentiality impact is rated none, the integrity impact is low, meaning attackers could alter data or device settings without authorization, potentially affecting device operation or patient data accuracy. There is no impact on availability. No known exploits have been reported in the wild, and no patches have been released at the time of publication. The vulnerability is classified as medium severity with a CVSS score of 5.3. The lack of authentication requirements and ease of exploitation make this a concern for environments where the device is accessible over untrusted networks. Medical equipment is often integrated into hospital networks and may interface with critical healthcare systems, increasing the risk if exploited. The vulnerability highlights the importance of proper access control implementation in medical devices to prevent unauthorized manipulation that could compromise patient safety or data integrity.

For European organizations, particularly healthcare providers using kamleshyadav Medicalequipment, this vulnerability poses a risk of unauthorized modification of medical device settings or data. Such integrity violations could lead to incorrect diagnostics, treatment errors, or compromised patient safety. Additionally, unauthorized access to medical equipment could undermine trust in healthcare IT systems and lead to regulatory non-compliance under GDPR and medical device regulations. The risk is heightened in environments where the device is connected to hospital networks without adequate segmentation or access controls. While availability and confidentiality impacts are not directly affected, the integrity compromise alone can have serious clinical consequences. The absence of known exploits reduces immediate risk, but the potential for future exploitation necessitates proactive mitigation. European healthcare institutions must consider this vulnerability in their risk assessments and incident response planning to avoid disruptions or harm caused by unauthorized device manipulation.

1. Implement strict network segmentation to isolate medical equipment from general-purpose networks and limit exposure to untrusted sources. 2. Enforce robust access control policies on the medical equipment, ensuring that authorization checks are correctly configured and tested. 3. Monitor network traffic and device logs for anomalous access attempts or unauthorized configuration changes. 4. Engage with the vendor (kamleshyadav) to obtain patches or updates addressing the vulnerability as soon as they become available. 5. Conduct regular security assessments and penetration testing focused on medical devices to identify and remediate access control weaknesses. 6. Apply compensating controls such as VPNs or secure tunnels for remote access to the devices. 7. Train healthcare IT staff on the importance of device security and incident response procedures related to medical equipment. 8. Maintain an inventory of affected devices and prioritize remediation based on criticality and exposure. 9. Collaborate with regulatory bodies to ensure compliance with medical device security standards and reporting requirements.